Lataa...
Modulation of the kallikrein/kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Bradykinin is the end-product of the kallikrein/kinin system, which has been recognized as an endogenous target for combating CNS inflammation. Angiotensin-converting enzyme (ACE) inhibitors influence the...
Tallennettuna:
| Julkaisussa: | Clin Exp Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Science Inc
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233374/ https://ncbi.nlm.nih.gov/pubmed/24996009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12413 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|